Feed Preview

Methyl-lysine Reader MPP8 (Keystone)

Methyl-lysine Reader MPP8 (Keystone) diagram by undefined

The Methyl-lysine reader M-Phase Phosphoprotein 8 (MPP8) or MPHOSPH8 binds to methylated histone H3K9 and can potentially lead changes in chromatin structure or recruit other proteins. Discover the latest research on methyl-lysine reader MPP8 here.

Top 20 most recent papers
55
1
European Journal of Medical Genetics

A new large deletion in the DFNB1 locus causes nonsyndromic hearing loss

European Journal of Medical GeneticsDecember 23, 2008
Delphine FeldmannFlorence Fellmann
Epigenetics & Chromatin

H3K9me3-binding proteins are dispensable for SETDB1/H3K9me3-dependent retroviral silencing

Epigenetics & ChromatinJuly 22, 2011
Irina A MaksakovaMatthew C Lorincz
Nature Microbiology

HIV-2/SIV viral protein X counteracts HUSH repressor complex

Nature MicrobiologyJune 13, 2018
Ghina ChouguiFlorence Margottin-Goguet
50
49
Nature

NP220 mediates silencing of unintegrated retroviral DNA

NatureNovember 30, 2018
Yiping ZhuStephen P Goff
45
121
1
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society

Humanin: Functional Interfaces with IGF-I

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research SocietyApril 16, 2016
J XiaoK Yen

See more papers from this feed

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/methyl-lysine-reader-mpp8-keystone/c19352b0-ee5f-42fa-b76a-feb94f51d609